Constrictive pericarditis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Hudakarman (talk | contribs) |
||
| (27 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Constrictive pericarditis}} | {{Constrictive pericarditis}} | ||
{{CMG}} | {{CMG}} Associate Editor in Chief: {{MUT}} | ||
==Overview== | |||
Pericardial constriction is a progressive disease without spontaneous reversal of the pericardial thickening. Some patients can be medically managed for several years. [[Edema]] can be controlled with [[diuretic]]s and slowing of the heart rate can maximize the diastolic filling time. Most patients eventually develop significant debility from impaired [[cardiac output]] and elevated right and left sided filling pressures. | |||
==Medical Therapy== | |||
A few case series since 1987 have mentioned transient constrictive pericarditis that appears to be associated with pericardial inflammation. The use of [[cardiac]] [[MRI]] has made it possible to identify [[pericardial]] [[inflammation]] with the use of late [[gadolinium]] enhancement. This particular type of constrictive pericarditis can be treated with anti-[[inflammatory]] [[therapy]] and prevent its progression to irreversible disease requiring [[pericardiectomy]] | |||
Transient pericarditis can be treated medically by: | |||
* NSAIDS | |||
* Steroids | |||
* Heart failure management | |||
* Chemotherapy | |||
If medical therapy fails, transient pericarditis can be treated by pericardiectomy | |||
Chronic constrictive pericarditis: | |||
* Complete pericardiectomy | |||
*Pericardiectomy is associated with 5-10% peri-operative mortality | |||
==2015 ESC Guidelines for the management of pericardial diseases: (DO NOT EDIT) <ref name="pmid263201122">{{cite journal| author=Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J et al.| title=2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). | journal=Eur Heart J | year= 2015 | volume= 36 | issue= 42 | pages= 2921-2964 | pmid=26320112 | doi=10.1093/eurheartj/ehv318 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26320112 }}</ref>== | |||
'''Recommendations for therapy of constrictive pericarditis:''' | |||
{|class="wikitable" style="width: 80%;" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>1. The mainstay of treatment of chronic permanent constriction is pericardiectomy" <nowiki>"</nowiki>1. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|- | |||
|bgcolor="LightGreen" |<nowiki>"</nowiki>2. Medical therapy of specific pericarditis (i.e tuberculous pericarditis) is recommended to prevent the progression of constriction ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width: 80%;" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Empiric anti-inflammatory therapy may be considered in cases with transient or new diagnosis of constriction with concomitant evidence of pericardial inflammation (i.e. CRP elevation or pericardial inflammation (i.e. CRP elevation or pericardial enhancement on CT/CMR) ''[[ACC AHA guidelines classification scheme#Level of Evidence|(Level of Evidence:]] C )''<nowiki>"</nowiki> | |||
|- | |||
|} | |||
== | ==Sources== | ||
* 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)<ref name="pmid263201122" /> | |||
==References== | ==References== | ||
Latest revision as of 15:53, 19 December 2019
|
Constrictive Pericarditis Microchapters |
|
Differentiating Constrictive Pericarditis from other Diseases |
|---|
|
Treatment |
|
Case Studies |
|
Constrictive pericarditis medical therapy On the Web |
|
American Roentgen Ray Society Images of Constrictive pericarditis medical therapy |
|
Risk calculators and risk factors for Constrictive pericarditis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor in Chief: M.Umer Tariq [2]
Overview
Pericardial constriction is a progressive disease without spontaneous reversal of the pericardial thickening. Some patients can be medically managed for several years. Edema can be controlled with diuretics and slowing of the heart rate can maximize the diastolic filling time. Most patients eventually develop significant debility from impaired cardiac output and elevated right and left sided filling pressures.
Medical Therapy
A few case series since 1987 have mentioned transient constrictive pericarditis that appears to be associated with pericardial inflammation. The use of cardiac MRI has made it possible to identify pericardial inflammation with the use of late gadolinium enhancement. This particular type of constrictive pericarditis can be treated with anti-inflammatory therapy and prevent its progression to irreversible disease requiring pericardiectomy
Transient pericarditis can be treated medically by:
- NSAIDS
- Steroids
- Heart failure management
- Chemotherapy
If medical therapy fails, transient pericarditis can be treated by pericardiectomy
Chronic constrictive pericarditis:
- Complete pericardiectomy
- Pericardiectomy is associated with 5-10% peri-operative mortality
2015 ESC Guidelines for the management of pericardial diseases: (DO NOT EDIT) [1]
Recommendations for therapy of constrictive pericarditis:
| Class I |
| "1. The mainstay of treatment of chronic permanent constriction is pericardiectomy" "1. (Level of Evidence: C)" |
| "2. Medical therapy of specific pericarditis (i.e tuberculous pericarditis) is recommended to prevent the progression of constriction (Level of Evidence: C)" |
| Class IIb |
| "1. Empiric anti-inflammatory therapy may be considered in cases with transient or new diagnosis of constriction with concomitant evidence of pericardial inflammation (i.e. CRP elevation or pericardial inflammation (i.e. CRP elevation or pericardial enhancement on CT/CMR) (Level of Evidence: C )" |
Sources
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)[1]
References
- ↑ 1.0 1.1 Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J; et al. (2015). "2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)". Eur Heart J. 36 (42): 2921–2964. doi:10.1093/eurheartj/ehv318. PMID 26320112.